11. Segment Reporting

3 Months Ended

Mar. 31, 2016

Segment Reporting [Abstract]

Segment Reporting

Selected financial information for the Company’s operating segments is as follows:

	Three Months Ended March 31,
	2016			2015
Net revenues - External
Clinical Laboratory Operations	$	1,465,137		$	13,499,803
Supportive Software Solutions		230,026			148,979
Decision Support and Informatics Operations		183,650			–
Corporate		–			–
Eliminations		–			–
	$	1,878,813		$	13,648,782
Net revenues - Inter Segment
Clinical Laboratory Operations	$	–		$	–
Supportive Software Solutions		296,348			384,108
Decision Support and Informatics Operations		–			–
Corporate		–			–
Eliminations		–			–
	$	296,348		$	384,108
Income (loss) from operations
Clinical Laboratory Operations	$	(2,650,540	)	$	5,065,421
Supportive Software Solutions		(1,313,313	)		(1,357,989	)
Decision Support and Informatics Operations		(881,566	)		–
Corporate		(1,952,437	)		(1,521,117	)
Eliminations		33,660			28,246
	$	(6,764,196	)	$	2,214,561
Depreciation and amortization
Clinical Laboratory Operations	$	581,101		$	447,325
Supportive Software Solutions		164,428			160,356
Decision Support and Informatics Operations		14,527			–
Corporate		875			1,358
Eliminations		(33,661	)		(28,246	)
	$	727,270		$	580,793
Capital expenditures
Clinical Laboratory Operations	$	16,885		$	187,885
Supportive Software Solutions		2,117			25,257
Decision Support and Informatics Operations		–			–
Corporate		–			–
Eliminations		–			–
	$	19,002		$	213,142

	March 31,			December 31,
	2016			2015
Total assets
Clinical Laboratory Operations	$	13,357,738		$	15,152,583
Supportive Software Solutions		2,677,943			2,896,473
Decision Support and Informatics Operations		3,714,571			4,307,053
Corporate		9,046,263			12,711,284
Eliminations		(6,327,245	)		(7,095,520	)
	$	22,469,270		$	27,971,873